Release Date: 25/10/11 12:39 Summary: Notice of Meeting and Annual Report dispatched Price Sensitive: No Download Document 2.12MB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%